Alzheimers & dementia, 1552-5260

Journal

  1. 2019
  2. NIMA Consortium, & Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease (2019). Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimer's and Dementia, 15(6), 776-787. https://doi.org/10.1016/j.jalz.2019.03.007
  3. 2016
  4. Hubin, E., Vanschoenwinkel, B., Broersen, K., De Deyn, P. P., Koedam, N., van Nuland, N. A., & Pauwels, K. (2016). Could ecosystem management provide a new framework for Alzheimer's disease? Alzheimers & dementia, 12(1), 65-74. https://doi.org/10.1016/j.jalz.2015.07.491
  5. 2015
  6. Sleegers, K., Bettens, K., De Roeck, A., Van Cauwenberghe, C., Cuyvers, E., Verheijen, J., ... BELNEU Consortium (2015). A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid A beta(42). Alzheimers & dementia, 11(12), 1452-1460. https://doi.org/10.1016/j.jalz.2015.02.013
  7. 2014
  8. Slaets, S., Vanmechelen, E., Le Bastard, N., Decraemer, H., Vandijck, M., Martin, J-J., ... Engelborghs, S. (2014). Increased CSF alpha-synuclein levels in Alzheimer's disease: Correlation with tau levels. Alzheimers & dementia, 10(5), S290-S298. https://doi.org/10.1016/j.jalz.2013.10.004
  9. 2013

ID: 5959891